VC-backed Sensei Biotherapeutics raises $133m for IPO
Sensei Biotherapeutics, a developer of next-generation cancer treatments, has raised about $133 million for its IPO after pricing its over 7 million shares at $10 per share.
4 February 2021•3 mins read
